Quentin Massé, auteur sur Theradiag

Presentation of the 2020 half-year results (only available in french) – 2020, 22nd September

Post author:Quentin Massé
Post published:22 September 2020
Post category:Financial presentations

Theradiag will hold a conference call to present H1 2020 results at 9:00am on September 22. To take part, please dial +33 1 72 72 74 03 followed by participant PIN code 24 52 93…

21/09/2020: French company Theradiag launches an antigen test in France to detect COVID-19 in less than 15 minutes

Post author:Quentin Massé
Post published:21 September 2020
Post category:Press Releases

Croissy-Beaubourg (77), September 21, 2020, 5:45 pm CEST - Theradiag, a French company specializing in diagnostic tests for autoimmune and infectious diseases, today announces the market launch of a CE-marked antigen test for detecting COVID-19.On…

21/09/2020: Theradiag publishes 2020 H1 results

Post author:Quentin Massé
Post published:21 September 2020
Post category:Press Releases

· Robust resilience in revenues at €4.9 million driven by Theranostic up +16.5% · Continued investment in R&D to drive future growth · North America business accelerates · Sound cash position at €1.7 million · Launch…

Presentation of the 2020 half-year results (only available in french) – 2020, 22nd September

21/09/2020: French company Theradiag launches an antigen test in France to detect COVID-19 in less than 15 minutes

21/09/2020: Theradiag publishes 2020 H1 results

“9èmes journées MICI OUEST”

GEAI Colloquium

12th International Congress on Autoimmunity 2020